Kalpana Mujoo
- Molecular Biology top 5%
- Oncology top 5%
- Immunology top 10%
- Neurology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- David A. ChereshRalph A. ReisfeldMichael D. PierschbacherMichaela HerzigFerid MuradDavid J. BaileyValsala HaridasJordan U. Gutterman
- Topics
- Monoclonal and Polyclonal Antibodies Research (15 papers)Glycosylation and Glycoproteins Research (7 papers)Toxin Mechanisms and Immunotoxins (7 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Kalpana Mujoo
47 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 101
- Molecular Biology 1.3k
- Oncology 480
- Immunology 423
- Neurology 403
- Radiology, Nuclear Medicine and Imaging 356
Countries citing papers authored by Kalpana Mujoo
This map shows the geographic impact of Kalpana Mujoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalpana Mujoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalpana Mujoo more than expected).
Fields of papers citing papers by Kalpana Mujoo
This network shows the impact of papers produced by Kalpana Mujoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalpana Mujoo. The network helps show where Kalpana Mujoo may publish in the future.
Co-authorship network of co-authors of Kalpana Mujoo
This figure shows the co-authorship network connecting the top 25 collaborators of Kalpana Mujoo. A scholar is included among the top collaborators of Kalpana Mujoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalpana Mujoo. Kalpana Mujoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 29 | |
| 2 | 11 | |
| 3 | 11 | |
| 4 | 15 | |
| 5 | 8 | |
| 6 | 28 | |
| 7 | 15 | |
| 8 | 56 | |
| 9 | 33 | |
| 10 | 6 | |
| 11 | 16 | |
| 12 | 9 | |
| 13 | 23 | |
| 14 | 34 | |
| 15 | 86 | |
| 16 | 5 | |
| 17 | 21 | |
| 18 | Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. | 215 |
| 19 | 0 | |
| 20 | 30 |
About Kalpana Mujoo
Kalpana Mujoo is a scholar working on Biotechnology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (7 papers) and Toxin Mechanisms and Immunotoxins (7 papers). The work is most often cited by research in Neurology (403 citations), Immunology (423 citations) and Immunology and Allergy (113 citations). Kalpana Mujoo has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include David A. Cheresh, Ralph A. Reisfeld, Michael D. Pierschbacher, Michaela Herzig, Ferid Murad, David J. Bailey, Valsala Haridas, Jordan U. Gutterman, Gamini S. Jayatilake and Joshua S. Krumenacker. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.